• 1
    Moayyedi P, Axon AT. Is there a rationale for eradication of Helicobacter pylori? Cost–benefit: the case for. Br Med Bull 1998; 54: 24350.
  • 2
    Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798810.
  • 3
    Williams B, Luckas M, Ellingham JH, Dain A, Wicks AC. Do young patients with dyspepsia need investigation? Lancet 1988; 2: 134951.
  • 4
    Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 105565.
  • 5
    Champion MC, MacCannell KL, Thomson AB, et al. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Can J Gastroenterol 1997; 11: 12734.
  • 6
    Chung JM. Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial. Scand J Gastroenterol (Suppl) 1993; 195: 114.
  • 7
    Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 16977.
  • 8
    Allescher M, Hartung J, Bockenhauff A, Knapp G, Wienbeck Q. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36: 93441.
  • 9
    Talley NJ. Non-ulcer dyspepsia: myths and realities. Aliment Pharmacol Ther 1991; 5(Suppl): 62.
  • 10
    Bytzer P, Moller Hansen J, Schaffalittzky de Muckadell O. Treatment of non-ulcer dyspepsia: are prokinetics effective? Scand J Gastroenterol 2002; 37: 61720.
  • 11
    Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 2058.
  • 12
    Soo S, Moayyedi P, Deeks J, Delaney B, Innes M, Forman D . Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews [computer file] 2000; CD001960.
  • 13
    Working Party. Management of dyspepsia: report from a Working Party. Lancet 1988; i: 5768.
  • 14
    Talley NJ, Colin-Jones DG, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 14560.
  • 15
    Casiraghi A, Ferrara A, Lesinigo E. Cimetidine vs antacids in non-ulcer dyspepsia. Curr Ther Res Clin Exp 1986; 39: 397(Abstract).
  • 16
    Misra SP, Dwivedi M, Misra V, Agarwal SK. Sucralfate versus ranitidine in non-ulcer dyspepsia: results of a prospective, randomized, open, controlled trial. Indian J Gastroenterol 1992; 11: 78.
  • 17
    Al-Quorain A, Larbi EB, Al-Shedoki F. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia. Scand J Gastroenterol 1995; 30: 5314.
  • 18
    Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979; 55(Suppl.): 2.
  • 19
    De Nutte N, Van Ganse W, Witterhulghe M, Defrance P. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. Clin Ther 1989; 11: 628.
  • 20
    Francois I, De Nutte N. Nonulcer dyspepsia: effect of the gastrointestinal prokinetic drug cisapride. Curr Ther Res 1987; 41: 8918.
  • 21
    Hannon R. Efficacy of cisapride in patients with nonulcer dyspepsia. A placebo-controlled study. Curr Ther Res Clin Exp 1987; 42: 81422.
  • 22
    Hansen JM, Bytzer P, Schaffalitzky de Muckadell O. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 36874.
    Direct Link:
  • 23
    Kellow JE, Cowan H, Shuter B, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 15360.
  • 24
    Rosch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987; 22: 1614.
  • 25
    De Groot GH, De Both PSM. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997; 11: 1939.
  • 26
    Agorastos I, Akriviadis E, Goulis G. Effect of cisapride in nonulcer dyspepsia: a placebo-controlled trial. Curr Ther Res Clin Exp 1991; 49: 8707.
  • 27
    Jian R, Ducrot F, Ruskone A, et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34: 65764.
  • 28
    Delattre M, Malesky M, Prinzie A. Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Curr Ther Res 1985; 37: 98091.
  • 29
    Gotthard R, Bodemar G, Brodin U, Jonsson KA. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 718.
  • 30
    Hadi S. Clinical investigation of ranitidine in patients with gastritis. Clin Ther 1989; 11: 5904.
  • 31
    Kelbaek H, Linde J, Eriksen J, Mungaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 2817.
  • 32
    Nesland AA, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985; 20: 62935.
  • 33
    Saunders JH, Oliver RJ, Higson DL. Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice. Br Med J Clin Res Ed 1994; 1986: 6658.
  • 34
    Singal AK, Kumar A, Broor SL. Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study. Curr Med Res Opin 1989; 11: 3907.
  • 35
    Muller P, Hotz J, Franz E, Simon B. Ranitidin in der Behandlung der Non-Ulcer-Dyspepsie. Eine placebo-kontrollierte Studie in der Bundesrepublic Deutschland. Arzneim-Forsch/Drug Res 1994; 10: 11302.
  • 36
    Blum AL, Arnold R, Stolte M, Fischer M, Koelz HR. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. Gut 2000; 47: 47380.
  • 37
    Olubuyide IO, Atoba MA. Non-ulcer dyspepsia in Nigerians: clinical and therapeutic results. Scand J Gastroenterol Suppl 1986; 124: 837.
  • 38
    Kang JY, Tay HH, Wee A, Guan R, Math MV, Yap I. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Gut 1990; 31: 47680.
  • 39
    Kazi JI, Jafarey NA, Alam SM, et al. A placebo controlled trial of bismuth salicylate in Helicobacter pylori associated gastritis. J Pakistan Med Assoc 1990; 40: 1546.
  • 40
    Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J. Campylobacter pylori — a role in non-ulcer dyspepsia? Scand J Gastroenterol Suppl 1989; 160: 713.
  • 41
    Loffeld RJ, Potters HV, Stobberingh E, Flendrig JA, Van Spreeuwel JP, Arends JW. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 1989; 30: 120612.
  • 42
    Vaira D, Holton J, Ainley C, et al. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Ital J Gastroenterol 1992; 24: 4004.
  • 43
    Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 1991; 26: 112331.
  • 44
    Kumar M, Yachha SK, Aggarwal R, et al. Healing of chronic antral gastritis: effect of sucralfate and colloidal bismuth subcitrate. Indian J Gastroenterol 1996; 15: 903.
  • 45
    Gudjonsson H, Oddsson E, Bjornsson S, et al. Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study. Scand J Gastroenterol 1993; 28: 96972.
  • 46
    Kairaluoma MI, Hentilae R, Alavaikko M, et al. Sucralfate versus placebo in treatment of non-ulcer dyspepsia. Am J Med 1987; 83: 515.
  • 47
    Carvalhinhos A, Fidalgo P, Freire A, Matos L. Cisapride compared with ranitidine in the treatment of functional dyspepsia. Eur J Gastroenterol Hepatol 1995; 7: 4117.
  • 48
    Fumagalli I, Hammer B. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand J Gastroenterol 1994; 29: 337.
  • 49
    Halter F, Staub P, Hammer B, Guyot J, Miazza BM. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. J Physiol Pharmacol 1997; 48: 18592.
  • 50
    Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. Scand J Gastroenterol Suppl 1993; 195: 4752.
  • 51
    Creytens G. Effect of the non-antidopaminergic drug cisapride on postprandial nausea. Curr Ther Res 1984; 36: 106370.
  • 52
    Testoni PA, Bagnolo F, Fanti L, Passaretti S, Tittobello A. Long-term oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients. Gut 1990; 31: 28890.
  • 53
    Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. Clin Ther 1987; 10: 4451.
  • 54
    Wood SF, Penney SC, Cochran KM. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. Scand J Gastroenterol Suppl 1993; 195: 510.
  • 55
    Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomised placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002; 16: 16418.
  • 56
    Yeoh KG, Kang JY, Tay HH, et al. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. J Gastroenterol Hepatol 1997; 12: 138.
  • 57
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 62934.
  • 58
    Redstone HA, Barrowman N, Veldhuyzen Van Zanten SJ. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001; 15: 12919.
  • 59
    Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 68996.
  • 60
    Anonymous. From the Food and Drug Administration. J Am Med Assoc 2000; 283: 2228.
  • 61
    Smalley W, Shatin D, Wysowski DK, et al. Contraindicated use of cisapride: impact of food and drug administration regulatory action. J Am Med Assoc 2000; 284: 30369.
  • 62
    Nyren O. Secretory abnormalities in functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl. 182): 258.
  • 63
    Anonymous. An evidence-based appraisal of reflux disease management — the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S116.
  • 64
    Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 10239.